Introduction
Aminoacyl-tRNA synthetase (ARS) catalyzes the ligation of a specific amino acid to its cognate tRNA, using ATP, thereby ensuring faithful translation of the genetic code (Kim et al., 2011; Park et al., 2008) . Aminoacyl-tRNA synthetaseinteracting multifunctional protein 1 (AIMP1) has been identified as a nonenzymatic factor associated with the ARS complex, which consists of nine different enzymes (Cirakoglu et al., 1985; Mirande et al., 1982; Norcum, 1989) and three non-enzymatic factors (Lee et al., 2004; Quevillon and Mirande, 1996; Quevillon et al., 1997; Quevillon et al., 1999) . AIMP1 regulates the catalytic reaction of arginyltRNA synthetase (RRS) as well as the stability of the ARS complex through proteinprotein interaction (Park et al., 1999; Han et al., 2006) . AIMP1 is associated with various physiological functions, including angiogenesis (Park, et al., 2002b) , wound healing (Park et al., 2005) , and autoimmunity (Han et al., 2007) . It is also highly enriched in pancreatic α cells, from which it is secreted to maintain glucose homeostasis (Park, et al., 2006) . Adipose tissue is one the most dynamic types of tissue in the body and is a critical exchange center for complex energy transactions (Galic et al., 2010; Haque and Garg, 2004; Rosen and Spiegelman, 2006) . However, an imbalance between energy intake and expenditure leads to metabolic disorders (Méndez-Sánchez, et al., 2006; Kalra et al., 2002) . Adipogenesis, the cell differentiation mechanism by which preadipocytes become adipocytes, entails complex processes and steps such as Journal of Cell Science Accepted manuscript commitment of preadipocytes, growth-arrest, clonal expansion, terminal differentiation, and maturation of adipocytes (Grimaldi, 2001; Ntambi and YoungCheul, 2000) . The terminal stages of adipogenic differentiation have been extensively studied using immortalized preadipocyte lines (Couture et al., 2009; Han, et al., 2012) .
Adipogenesis is governed by a multifaceted transcriptional regulatory cascade.
Three classes of transcription factors are known to influence adipogenesis directly.
These include peroxisome proliferator-activated receptor gamma (PPARγ), member of the CCAAT/enhancer-binding protein families (C/EBPs), and members of the basic helix-loop-helix family (ADD1/SREBP1c) (Rosen et al., 2000) . PPARγ is a member of the nuclear-receptor family of ligand-activated transcription factors that is highly expressed in white adipose tissues, where it is required for adipocyte differentiation (Koppen and Kalkhoven, 2010; Tontonoz et al., 2008) . Accumulating evidence has suggested that no factor is capable of guiding cells to differentiate into adipocytes in the absence of PPARγ, whereas forced expression of PPARγ is sufficient to induce differentiation of fibroblasts into adipocytes (Rosen et al., 1999; Tontonoz et al., 1994) . PPARγ activates the promoter of the gene encoding C/EBPα, and vice versa, creating a positive-feedback loop. In addition, PPARγ and C/EBPα induce the expression of genes that are involved in insulin sensitivity, lipogenesis, and lipolysis (Lefterova et al., 2008) .
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The sirtuin SIRT2, inhibits PPARγ indirectly by reducing the levels of acetylation of forkhead box O1 (FOXO1). This leads to an increase in the nuclear localization of FOXO1, where it represses the transcription of the gene encoding PPARγ (Jing et al., 2007) . Another sirtuin, SIRT1, impairs adipogenesis by directly acting as a PPARγ co-repressor (Picard et al., 2004) . The nuclear co-repressor (NCoR) and silencing mediator of retinoid and thyroid hormone (SMRT) proteins have been identified as nuclear receptor corepressors controlling transcriptional activity of PPARγ (Cohen et al. 1998; Yu et al., 2005) . NCoR and SMRT recruit a complex exhibiting histone deacetylase activity to repress transcription of target genes. In addition, NCoR and SMRT are recruited by other nuclear receptors and interact with nuclear receptor corepressors in a ligand-dependent manner (Cohen, 2006; Yu et al., 2005) .
Although PPARγ is known as an important factor playing a role in the strict control of adipogenesis, little is known about the regulation of PPARγ activity through protein-protein interaction. In this study, we show the molecular mechanisms by which AIMP1 regulates adipocyte differentiation through the catalytic inhibition of PPARγ.

Results
Dynamic alteration of AIMP1 expression during the differentiation of 3T3-L1 preadipocytes
During adipocyte differentiation, the gene expression profile changes markedly.
While the adipogenic role attributed to the white adipose tissue (WAT) is energy storage, protein synthesis is an energy-consuming process (Trayhurn and Beattie, 2001; Rosen et al. 2000) . Here, we specifically investigated the changes in expression of genes encoding tRNA synthetases and their associated factors that are involved in protein synthesis during adipogenesis. While the expression of genes encoding adipogenic markers, such as lipoprotein lipase (LPL), RXRα, and sterol regulatory element-binding transcription factor 1 (SREBP1), was increased during the differentiation of 3T3-L1 cells, the expression of SIRT1 was decreased, as was the expression of genes encoding ten different tRNA synthetases, glutamyl-prolyltRNA synthetase (EPRS), methionyl-tRNA synthetase (MRS), isoleucyl-tRNA synthetase (IRS), valyl-tRNA synthesis (VRS), tryptophanyl-tRNA synthetase (WRS), aspartyl-tRNA synthetase (DRS), arginyl-tRNA synthetase (RRS), leucyltRNA synthetase (LRS), glycyl-tRNA synthetase (GRS), and histidyl-tRNA synthetase (HRS), and that of genes encoding two AIMPs, AIMP2 and AIMP3 (Fig.   1A ). These findings suggest that aminoacyl-tRNA synthesis and ATP consumption is decreased during adipogenesis. However, the expression pattern of the gene encoding AIMP1 was different from that of genes encoding AIMP2 and AIMP3.
AIMP1 expression peaked at 4-6 days after differentiation ( Fig. 1A and 1B) . While the protein expression of AIMP1 was slightly delayed, peaking only at 6-8 days after differentiation, the expression of RRS, which is a binding partner of AIMP1 within the multi-tRNA synthetase complex, remained unchanged during adipocyte differentiation (Fig. 1C) . In addition, we also examined AIMP1 expression during adipose tissue development in mice. RT-PCR analysis was performed on RNA isolated from the developing WAT fractions at pre-and postnatal time points (Birsoy et al., 2011) . As shown in Fig. 1D , AIMP1 mRNA was expressed relatively low in early embryonic (E15.5 and E16.5) and postnatal time points (P2 and P4), but its expression was greatly increased at E18.5 and P0 (Fig. 1D) , consistent with AIMP1 expression in 3T3-L1 cells (Fig. 1B) . Taken together, these results suggested that the stoichiometry of AIMP1 to RRS is altered and that AIMP1 has a novel function during adipocyte differentiation.
Nuclear localization of AIMP1 during adipogenesis
To examine the function of AIMP1 during adipocyte differentiation, we first analyzed the subcellular localization of AIMP1. As shown in Fig. 2A , a portion of AIMP1 was clearly localized to the nucleus in differentiated 3T3-L1 adipocytes, but not in preadipocytes. Although AIMP1 was mainly expressed in the cytoplasm in 3T3-L1 preadipocytes, AIMP1 level was increased and translocated to the nucleus in mature adipocyte, where it colocalized with propidium iodide (PI) staining.
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Biochemical fractionation also showed an increase in AIMP1 in both the cytoplasm and nucleus during adipogenesis (Fig. 2B) .
To clarify the region of AIMP1 responsible for its nuclear translocation, we generated two truncated mutants of AIMP1 such as C-terminal truncated (amino acids [a.a.] 1-146) or N-terminal truncated mutant (a.a. 146-312). As shown in Fig.   2C , the N-terminal truncated mutant was mainly located in the nucleus while the Cterminal truncated mutant still showed cytoplasmic staining (Fig. 2C) . To identify the residue of AIMP1 responsible for its nuclear translocation, we searched the candidate nuclear localization signal (NLS) of AIMP1 C-terminus using bioinformatics tools and found out one candidate NLS-triple lysine residues ( 267 KKK 269 ) of AIMP1 C-terminus (Fig. 2D ). If these triple lysine residues are mutated to triple alanine residues, the mutated AIMP1 (KKK267-269AAA) cannot translocate to the nucleus (Fig. 2E ). These results indicate that AIMP1 translocates to the nucleus via its NLS during adipocyte differentiation.
Since AIMP1 can function as a secreted factor (Park et al., 2002a; Park et al., 2005; Park et al., 2006; Han et al., 2010) , we examined whether AIMP1 is secreted during adipogenesis. While adiponectin, an adipokine produced and secreted by adipocytes, was detected in the culture media of adipocytes, AIMP1 was not detected (Fig. 2F ). Taken together, these results also suggested that AIMP1 has a novel function, in the nucleus, during adipogenesis.
Negative regulation of adipogenesis by AIMP1
To investigate the effect of AIMP1 on adipogenesis, we used AIMP1-deficient mouse embryonic fibroblasts (MEFs) and 3T3-L1 preadipocytes that had been transfected with AIMP1-specific siRNA. The mRNA expression of adipogenic genes, such as those encoding acyl-CoA synthetase (ACS), fatty acid synthase (FAS), and SREBP-1, was elevated in AIMP1-deficient MEFs compared to that in wild type cells by 8 days after differentiation (Fig. 3A) . The same results were observed in the AIMP1 siRNA-transfected 3T3-L1 cells (Fig. 3B ).
When the accumulation of intracellular lipids was monitored by Oil-red O staining, the intensity of Oil-red O staining was increased in AIMP1-deficient MEFs and in AIMP1 down-regulated cells ( Fig. 3C and 3D ). In addition, the triglyceride (TG) content was elevated in AIMP1-deficient MEFs and in AIMP1 down-regulated cells during adipogenesis ( Fig. 3E and 3F ). Expression of adipogenic proteins (aP2, RXRα, and C/EBPα) rapidly increased in AIMP1-deficient MEFs and in AIMP1
down-regulated cells, as compared to control cells ( Fig. 3G and 3H ).
To examine whether AIMP1 overexpression suppresses adipogenesis, we generated cell lines with inducible AIMP1, which was overexpressed in the absence of tetracycline (tet). As shown in Fig. 4A (Fig. 4D) . Furthermore, accumulation of intracellular lipid droplets and TG content was suppressed in cells infected with the AIMP1-adenovirus compared with the LacZ-adenovirus ( Fig. 4E and 4F). Taken together, these results indicated that AIMP1 inhibits adipogenesis.
Negative effect of AIMP1 on adipogenesis in vivo
To validate the effect of AIMP1 on adipogenesis in vivo, we injected the LacZor AIMP1-adenovirus into mouse epididymal fat pads. The epididymal fat pads (which are WAT), liver, and muscle tissues were removed from sacrificed mice and the expression of AIMP1 and adipogenic markers was analyzed. When adenoviruses expressing either AIMP1 or LacZ were injected into the fat pads, the expression of AIMP1 in the liver and muscle tissues was not affected ( 
Negative regulation of PPARγ by AIMP1
To elucidate how AIMP1 regulates adipogenesis, we first examined the effect of AIMP1 on the transcriptional activities of PPARγ, SREBP1c, and ERRγ, which are the major transcription factors involved in adipogenesis (Kim et al., 1998; Spiegelman 1998; Kubo et al., 2009) . Although AIMP1 had no effect on the transcriptional activities of SREBP1c and ERRγ (Supplementary materials Fig. 1A and 1B), AIMP1 suppressed PPARγ transcriptional activity in dose-dependent manner, as well as RXRα-induced PPARγ transcriptional activity ( Fig. 6A and 6B).
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Since AIMP1 mutant (KKK267-269AAA) cannot tanslocate to the nucleus ( These results suggest that nuclear translocation of AIMP1 is important for negative regulation of PPARγ.
Next, we investigated the association between PPARγ and AIMP1. Endogenous AIMP1 interacted with PPARγ in 3T3-L1 adipocytes ( Fig. 6C ). To assess whether AIMP1 binds specifically to particular isoforms of PPAR, we overexpressed either GFP-tagged PPARγ or PPARδ in 293T cells that expressed myc-tagged AIMP1.
AIMP1 co-immunoprecipitated with GFP-PPARγ, but not with GFP-PPARδ ( We then examined whether the conformation of PPARγ affects AIMP1 binding.
Purified PPARγ was incubated with GST alone or GST-AIMP1 in the presence of GW9662 (a PPARγ antagonist) or rosiglitazone (a PPARγ agonist), followed by immunoblot analysis. Rosiglitazone, but not GW9662, significantly increased the binding affinity of PPARγ for AIMP1 (Fig. 6F) . Since AIMP1 interacted with the DNA-binding domain of PPARγ and suppressed its transcriptional activity, we investigated whether AIMP1 directly inhibits the binding of PPARγ to the peroxisome proliferator-activated receptor response element (PPRE) on the DNA. Here, we showed that, in adipose tissues, AIMP1 negatively regulates PPARγ and adipogenesis.
AIMP1 overexpression in WAT can affect blood levels of TNFα, insulin, adiponectin, NEFA, and TG. Thus, to some extent, the metabolic phenotypes of AIMP1 -/-mice may be due to intracellular AIMP1 depletion and activation of PPARγ activity. Interestingly, liver PPARγ contributes to hepatic steatosis (Gavrilova et al., 2003; Yu et al., 2003) , and AIMP1 -/-mice show a hepatic steatosis phenotype (data not shown), which may be caused by hepatic elevation of PPARγ activity.
For adipocyte differentiation, cells first undergo growth-arrest, re-enter the cell cycle under the influence of differentiation inducers, undergo mitotic clonal expansion, and finally exit the cell cycle to undergo terminal differentiation (Gao et al., 2013; Tang et al., 2003) . During the early phase of adipocyte differentiation, AIMP1 levels increase; the protein then translocates to the nucleus, where it interacts with and inhibits the transcriptional activity of PPARγ (Fig. 2B, Fig. 6A ).
As shown in Fig. 1A , the mRNA of SIRT1, a known repressor of PPARγ, was decreased during adipogenesis. Although SIRT1 mRNA was decreased, PPARγ activity was not always high, indicating that other repressors are needed for the fine-control of PPARγ activity during adipogenesis. Here, we suggest that AIMP1 is a novel inhibitor of PPARγ activity, and that the joint action of AIMP1 and SIRT1 in fine-tuning PPARγ activity may be required for control of adipogenesis.
Moreover, FOXO1 and SIRT2 are known to inhibit adipogenesis through PPARγ inhibition. Adipogenesis is regulated by acetylation/deacetylation of FOXO1, which is mediated by SIRT2. SIRT2 decreases the acetylation levels of FOXO1, which increases its binding to PPARγ, which, in turn, inhibits the transcriptional activity of PPARγ (Jing et al., 2007) . FOXO1 also interacts with PPARγ in a rosiglitazone-dependent manner, but the regions responsible for binding of PPARγ to and PPARγ revealed here also provides a novel pharmacological space to deal with metabolic syndrome such as obesity.
Materials and Methods
Quantitative RT-PCR (qPCR)
Total RNA was isolated using TRIzol Reagent (Molecular Research Center, Cincinnati, OH, USA), according to the manufacturer's instructions. Total RNA was quantified by absorbance at 260 nm and the integrity of the RNA was checked using the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Target primer set sequences were acquired from the PrimerBank database or were designed using GenScript Real-time PCR primer design software (Supplementary Table. 1). RNA (1 µg) was reverse transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). qPCR was performed, in duplicate, using SYBR green (Qiagen, Hilden, Germany) and a Mx3000P (Agilent, Santa Clara, CA, USA). qPCR was performed using the following PCR cycling conditions: 95°C for 10 min, followed by 40 cycles each consisting of 95°C for 15 s, 55°C or 60°C for 30 s, and 72°C for 30 s. The relative abundance of specific mRNAs was calculated by normalization to the levels of the gene encoding glyceraldehyde-3-phosphate dehydrogenase.
Oil-red O staining and triglyceride measurement
Oil-red O staining was performed as described previously (Wu et al., 1998) . 
Measurement of AIMP1 and adiponectin in the culture medium
For the measurement of AIMP1 and adiponectin, cell culture medium was harvested at the indicated day, and clarified by centrifugation at 4000 x g for 15 min. The levels of AIMP1 and adiponectin in the medium were measured using ELISA kits according to the manufacturer's instructions.
Western blotting
Cells were lysed with RIPA buffer (1% NP-40, 1% Na-deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris pH 7.4, and 2 mM EDTA, 50 mM NaF) and incubated on ice for 30 min. The lysates were centrifuged for 20 min at 20,000 x g. 
Separation of stromal vascular fractions (SVF) and adipocyte fractions in mice
Embryos and postnatal days 0, 2, 4 from C57BL/6 mice were minced in PBS with calcium chloride and 0.5% BSA. Tissue suspensions were centrifuged at 500g for 5 min to remove erythrocytes and free leukocytes. Collagenase type II (Gibco;
Invitrogen, Carlsbad, CA, USA) was added to 1 mg/ml in DMEM and incubated at 37°C for 20 min with shaking. The cell suspensions were filtered through an 80 μm filter (BD bioscience, USA) and then spun at 300g for 5 min to separate floating adipocytes from the SVF pellet. To ensure proper isolation, adipocyte fractions were examined by microscopy before and after plating on plastic to detect adherent cells.
Total RNA was isolated from cell by RNeasy kit (Qiagen, Hilden, Germany) (Birsoy et al., 2011).
RT-PCR
RNA was extracted according to the protocols of the RNeasy kit (Qiagen, Hilden, Germany). RNA was reverse transcribed with M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and the cDNA was amplified by PCR and electrophoresed on ethidium bromide-agarose gels. Primers used for PCR were as follows: PPARγ-forward, 5′-CTGGTTTCATTAACCTTGATTTG-3′, PPARγ-reverse, 5′-ACAAGTCCTTGTAGATCTCCTG-3′, AIMP1-forward, 5′-CAG CAGTCGGCAGCAGCAAGTAC-3′, AIMP1-reverse, 5′-CACACTCAGCATTGGT
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GTGCAGG-3′, GAPDH-forward, 5′-GTGAAGGTCGGTGTGAACGGA-3′, GAPDH-reverse, 5′-CCCATCACAAACATGGGGGCA-3′.
Plasmids and transfection
Mouse AIMP1 cDNA was amplified from 3T3-L1 cells, digested with EcoRI and SalI enzymes, and cloned into a pcDNA3 vector (pcDNA3-mAIMP1). Human AIMP1 was amplified with a myc-tag encoding primer and cloned into pcDNA3
vector (myc-AIMP1), and the native form of human AIMP1 was amplified and cloned into a pGEX-4T1 vector (GST-AIMP1). pcDNA3-PPARγ2, PPREx3TK-Luc, and GST-PPARγ2 vectors were kindly provided by CS Shin (Seoul National University, Seoul, Korea) and the GFP-PPARγ vector was kindly provided by FJ Gonzalez (National Cancer Institute, USA). All transfection experiments were performed in the 3T3-L1 cell line, using electroporation (Neon, Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Voltage, pulse width, and pulse number for electroporation were adjusted to 2500 V, 9 ms, and 1, respectively, for the 3T3-L1 cell line. For the AIMP1 knockdown experiment, duplex RNAs were synthesized (Invitrogen; sequence: 5′-AACAATACAACCAATTCGAAGATCC-3′) and transfected by electroporation as described above. Stealth TM RNAi Negative Control Duplexes (Invitrogen, Carlsbad, CA, USA) were used as control.
Site directed mutagenesis
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GST-pull down and immunoprecipition
GST, GST-AIMP1, and GST-PPARγ2 proteins were purified as follows. Each vector was transformed into Rosetta cells and cultured in Luria broth (LB) media. Protein expression was induced by 0.5 mM IPTG, and cells were cultured at 18°C, for 9 h.
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Cells were pelleted, resuspended in protein lysis buffer (50 mM Tris pH 7.4, 120 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM EDTA, 1% Triton X-100, and 100 μ g/ml PMSF), and sonicated to disrupt cells. Cell lysates were centrifuged for 20 min at 20,000 x g; the supernatants were mixed with Glutathione Sepharose TM 4B
(GE Healthcare, Little Chalfont, UK) beads and rotated for 6 h at 4°C in order to bind proteins to the beads. 
Electrophoretic mobility shift assay (EMSA)
EMSA was performed using an EMSA "Gel-Shift" kit (Panomics, Fremont, CA, USA) according to the manufacturer's protocol. Briefly, eluted GST, or GST-AIMP1
proteins were incubated with differentiated 3T3-L1 nuclear extracts, binding buffer, poly d(I-C), and a biotin-labeled PPRE probe, before being separated by SDS-PAGE.
3T3-L1 nuclear extract was prepared by disruption and centrifugation of 3T3-L1
Journal of Cell Science Accepted manuscript cells in 0.5% NP-40 sucrose buffer. An unlabeled PPRE probe was used as the cold probe. Probe signals were detected by western blotting using a streptavidinhorseradish peroxidase conjugate.
Preparation of recombinant adenovirus
Recombinant adenovirus containing human AIMP1 cDNA was constructed using an Adenoviral Expression Kit (Clontech, Mountain View, CA, USA). Recombinant adenoviruses bearing the bacterial β-galactosidase gene (Adv-LacZ) was used as control.
Animals and in vivo adenovirus injection into the fat pad
Animal studies were conducted in accordance with the institutional guidelines for animal experiments of Seoul National University. Male C57BL/6 mice were housed individually, and high-fat-chow feeding (32% safflower oil, 33.1% casein, 17.6% sucrose, and 5.6% cellulose) was initiated at 5 weeks of age. After 4 weeks of highfat-chow loading, body-weight-matched mice were anesthetized prior to dissection of the skin and body wall. An adenoviral preparation (1 x 10 8 plaque-forming units in a volume of 20 μL) was injected at two points on each side of the epididymal fat pad and the subcutaneous fat tissues in the flank, i.e., each mouse was injected at a total of four points (Yamada et al., 2006) .
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Blood analysis
Blood AIMP1, serum insulin, adiponectin, TNFα, triglyceride, and NEFA levels were determined as previously described (Park et al., 2006) .
Intraperitoneal gluocose-tolerance test (IPGTT)
IPGTTs were performed on fasted (10 h, daytime) mice. Mice were given glucose (2 g/kg of body weight) intraperitoneally, followed by measurement of blood glucose levels. of C57BL/6 mice and quantitative RT-PCR was performed using specific primers.
Rosen
As a control, GAPDH mRNA levels were also quantified from the same RNA samples by RT-PCR. The level of each gene transcript was normalized to that of GAPDH. The data shown are representative of three independent experiments.
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